Literature DB >> 6668513

Progress in the treatment of plasma cell myeloma?

D Bergsagel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6668513     DOI： 10.1200/JCO.1983.1.8.510

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma.

Authors:  J Bladé; J San Miguel; A Alcalá; J Maldonado; J García-Conde; M J Moro; M A Sanz Sanz; C Alonso; A Zubizarreta; C Besses
Journal:  Blut       Date:  1990-06

2.  Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.

Authors:  M R Cooper; A Fefer; J Thompson; D C Case; R Kempf; R Sacher; J Neefe; J Bickers; J H Scarffe; R J Spiegel
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

3.  Controversies in the treatment of plasma cell myeloma.

Authors:  D E Bergsagel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.